Mechanism of streptococcus virulence regulation by bacterial peptide signals
Mechanism of streptococcus virulence regulation by bacterial peptide signals
批准号:
8721328
负责人:
Muthiah Kumaraswami
金额:
$19.69万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-15 至 2015-07-31
关键词:
Acute Rheumatic Heart DiseaseAnimalsAnti-Bacterial AgentsAnti-Infective AgentsAntibiotic ResistanceBindingBiochemicalBiophysicsC-terminalCell DensityCessation of lifeClinicalCommunicationCuesCulture MediaCysteine ProteaseDNADNA BindingDNA Binding DomainDNA SequenceDataDependenceDevelopmentDiseaseDisease OutbreaksEctopic ExpressionFoundationsFutureGene ExpressionGene Expression RegulationGeneticGenetic IdentityGenetic TranscriptionGoalsGrowthHumanImpetigoInfectionInfection ControlKnowledgeLaboratoriesLeadLifeMediatingMethodsModelingMolecularMorbidity - disease rateN-terminalNecrotizing fasciitisOrthologous GenePathogenesisPeptide HydrolasesPeptide Signal SequencesPeptidesPharyngeal structurePharyngitisPhasePhenotypePrincipal InvestigatorProteinsPublishingRegulationRegulator GenesResearchResearch ProposalsRoleSignal PathwaySignal TransductionSignal Transduction PathwaySiteSodium ChlorideStreptococcusStreptococcus pyogenesTestingTissuesToxic Shock SyndromeVaccinesVirulenceVirulence FactorsWorkantimicrobialbacterial geneticsbasedesigndrug discoveryfactor Aimprovedintercellular communicationmortalitymutantnovelnovel therapeuticspathogenprogramspromoterpublic health relevanceresponsescaffoldstreptococcal pyrogenic exotoxin Bstructural biologytherapeutic target
中文摘要
描述(申请人提供):A组链球菌(GAS)是一种人类独有的病原体,可导致严重的发病率和死亡率。鉴于最近气体侵袭性疾病暴发的增加、气体中的抗生素耐药性以及缺乏人类疫苗,不能忽视确定新的抗菌素靶标以改善感染控制的必要性。细菌细胞间通讯机制为抗菌药物的发现提供了一个很有前途的靶点,因为它提供了一种除生长抑制之外的感染控制手段。GAS全球转录调节因子RopB控制着几种毒力因子的表达,包括分泌型蛋白酶SpeB,它是宿主组织损伤和疾病传播所必需的。先前的数据表明,RopB需要生长阶段特定的环境信号来介导基因调控。最近,通过在结构生物学、生物物理学、细菌遗传学和细菌发病机制方面的专业实验室的共同努力,我们证明了RopB是气体通讯机制的一个组成部分,它利用生长阶段特异的分泌肽作为细胞间信号来协调毒力基因的调控。虽然我们在低细胞密度下鉴定了Vfr的分泌信号序列为RopB抑制信号,但高细胞密度下特异的激活信号的遗传同一性仍不清楚。这项研究计划旨在识别和表征这些肽信号,并评估它们对毒力的影响。这项提议的目的是加强对GAS中细胞间信号机制的分子理解,长期目标是设计针对细菌通信的抗感染策略。这项拟议的研究的成功完成不仅将提供溶血性链球菌细胞间信号转导的分子和机制细节,而且可能为未来抗感染药物的开发提供潜在的支架。
英文摘要
DESCRIPTION (provided by applicant): Group A Streptococcus (GAS) is an exclusive human pathogen that causes significant morbidity and mortality. Given the recent rise in GAS invasive disease outbreaks, antibiotic resistance in GAS and lack of a human vaccine, the need to identify novel antimicrobial targets to improve infection control cannot be ignored. The bacterial intercellular communication machinery offers a promising target for antibacterial drug discovery as it provides a means of infection control other than growth inhibition. GAS global transcription regulator, RopB, controls the expression of several virulence factors including secreted protease, SpeB, which is required for host tissue damage and disease dissemination. Previous data suggested that RopB requires growth-phase-specific environmental signals to mediate gene regulation. Recently, through the collaborative effort of laboratories with expertise in structural biology, biophysics, bacterial genetics, and bacterial pathogenesis, we demonstrated that RopB is a component of GAS communication machinery and it uses growth phase-specific secreted peptides as intercellular signals to coordinate virulence gene regulation. Although we identified the secretion signal sequence of Vfr as RopB inhibition signal at low cell density, the genetic identity of activation signals specific for high cell density remains unknown. This research proposal is designed to identify and characterize the peptide signals and assess their impact on GAS virulence. The objective of this proposal is to enhance molecular understanding of the intercellular signaling machinery in GAS with the long-term goal of devising anti-infective strategies that target bacterial communication. Successful completion of the proposed study would not only provide the molecular and mechanistic details of the intercellular signaling in ¿-hemolytic streptococci but also could potentially provide the scaffold for the development of future anti-infective drugs.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Adhesin competence repressor (AdcR) from Streptococcus pyogenes controls adaptive responses to zinc limitation and contributes to virulence.
化脓性链球菌的粘附素能力阻遏物 (AdcR) 控制着对锌限制的适应性反应并有助于毒力。
DOI:
10.1093/nar/gku1304
发表时间:
2015
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Sanson,Misu, Makthal,Nishanth, Flores,AnthonyR, Olsen,RandallJ, Musser,JamesM, Kumaraswami,Muthiah]
通讯作者:
Kumaraswami,Muthiah
A naturally occurring single amino acid replacement in multiple gene regulator of group A Streptococcus significantly increases virulence.
A 组链球菌的多基因调节因子中天然存在的单一氨基酸替代显着增加了毒力。
DOI:
10.1016/j.ajpath.2014.10.018
发表时间:
2015
期刊:
The American journal of pathology
影响因子:
--
作者:
[Sanson,Misu, O'Neill,BrianE, Kachroo,Priyanka, Anderson,JeffR, Flores,AnthonyR, Valson,Chandni, Cantu,ConcepcionC, Makthal,Nishanth, Karmonik,Christof, Fittipaldi,Nahuel, Kumaraswami,Muthiah, Musser,JamesM, Olsen,RandallJ]
通讯作者:
Olsen,RandallJ
Molecular Mechanism of Virulence Regulation in Streptococcus Pyogenes
-
批准号:10275779
-
项目类别:
-
资助金额:$56.37万
-
财政年份:2021
-
负责人:Muthiah Kumaraswami
-
依托单位:
Molecular Mechanism of Virulence Regulation in Streptococcus Pyogenes
-
批准号:10418819
-
项目类别:
-
资助金额:$56.37万
-
财政年份:2021
-
负责人:Muthiah Kumaraswami
-
依托单位:
Molecular Mechanism of Virulence Regulation in Streptococcus Pyogenes
-
批准号:10619021
-
项目类别:
-
资助金额:$56.37万
-
财政年份:2021
-
负责人:Muthiah Kumaraswami
-
依托单位:
Molecular mechanism of streptococcal adaptation to host nutritional defenses
-
批准号:10328270
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:Muthiah Kumaraswami
-
依托单位:
Molecular mechanism of streptococcal adaptation to host nutritional defenses
-
批准号:10559677
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:Muthiah Kumaraswami
-
依托单位:
Molecular mechanism of virulence regulation in Streptococcus pyogenes
-
批准号:9206980
-
项目类别:
-
资助金额:$39.88万
-
财政年份:2015
-
负责人:Muthiah Kumaraswami
-
依托单位:
Mechanism of streptococcus virulence regulation by bacterial peptide signals
-
批准号:8430906
-
项目类别:
-
资助金额:$22.21万
-
财政年份:2013
-
负责人:Muthiah Kumaraswami
-
依托单位:
海外基金